Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 1 of 1 for:    IntReALL 2010 SR
Previous Study | Return to List | Next Study

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01802814
Recruitment Status : Recruiting
First Posted : March 1, 2013
Last Update Posted : May 30, 2018
Australian and New Zealand Children's Haematology/Oncology Group
St. Anna Kinderkrebsforschung (Co-Sponsor Austria)
European Organisation for Research and Treatment of Cancer - EORTC
University Hospital Motol (Co-Sponsor Czech Republic)
Copenhagen University Hospital (Rigshospitalet) (Co-Sponsor Copenhagen)
Turku University (Co-Sponsor Finland)
Centre Hospitalier Universitaire de Nice
Our Lady's Chilrden's Hospital (Co-Sponsor Ireland)
Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel)
Ospedale Pediatrico Bambino Gesù (Co-Sponsor Italy)
National Hospital Organization Nagoya Medical Center (Co-Sponsor Japan)
Prinses Máxima Centrum (Co-Sponsor Netherlands)
Oslo University Hospital (Co-Sponsor Oslo)
Medical University of Wroclaw (Co-Sponsor Poland)
Instituto Português de Oncologia de Lisboa (Co-Sponsor Lisboa)
Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain)
University Hospital Stockholm (Co-Sponsor Sweden)
University Children's Hospital Zurich (Co-Sponsor Switzerland)
Central Manchester University (Co-Sponsor UK)
Information provided by (Responsible Party):
PD Dr. Arend von Stackelberg, Charite University, Berlin, Germany

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2023
Estimated Study Completion Date : November 2023